Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease

Virology

Volumn 322, Issue 1, 2004, Pages 168-181

  Song, Byeongwoon ^a   Cayabyab, Mark ^b   Phan, Ngoc ^a   Wang, Liping ^a   Axthelm, Michael K ^c   Letvin, Norman L ^b   Sodroski, Joseph G ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

AIDS; Rhesus macaque; Simian human immunodeficiency virus

Indexed keywords

CD4 ANTIGEN; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM; CHIMERA; DEATH; EXPLANT; GLYCOSYLATION; IMMUNE DEFICIENCY; MOLECULAR CLONING; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DOMAIN; RHESUS MONKEY; SENSITIVITY ANALYSIS; SIMIAN IMMUNODEFICIENCY VIRUS; TREMOR; VIRUS CHARACTERIZATION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS NEUTRALIZATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD4; BRAIN; DISEASE MODELS, ANIMAL; GLYCOPROTEINS; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; MACACA MULATTA; MOLECULAR SEQUENCE DATA; NERVOUS SYSTEM DISEASES; NEUTRALIZATION TESTS; REASSORTANT VIRUSES; SIMIAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; SIMIAE; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 1942421829     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.02.001     Document Type: Article

References (85)

1. Albright A.V., Shieh J.T., Itoh T., Lee B., Pleasure D., O'Connor M.J., Doms R.W., Gonzalez-Scarano F. Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J. Virol. 73(1):1999;205-213.
2. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272(5270):1996;1955-1958.
3. Allan J.S., Coligan J.E., Barin F., McLane M.F., Sodroski J.G., Rosen C.A., Haseltine W.A., Lee T.H., Essex M. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science. 228(4703):1985;1091-1094.
4. Barre-Sinoussi F., Chermann J.C., Rey F., Nugeyre M.T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vezinet-Brun F., Rouzioux C., Rozenbaum W., Montagnier L. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 220(4599):1983;868-871.
5. Brand D., Srinivasan K., Sodroski J. Determinants of human immunodeficiency virus type 1 entry in the CDR2 loop of the CD4 glycoprotein. J. Virol. 69(1):1995;166-171.
6. Burton D.R., Pyati J., Koduri R., Sharp S.J., Thornton G.B., Parren P.W., Sawyer L.S., Hendry R.M., Dunlop N., Nara P.L.et al. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science. 266(5187):1994;1024-1027.
7. Calarese D.A., Scanlan C.N., Zwick M.B., Deechongkit S., Mimura Y., Kunert R., Zhu P., Wormald M.R., Stanfield R.L., Roux K.H., Kelly J.W., Rudd P.M., Dwek R.A., Katinger H., Burton D.R., Wilson I.A. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science. 300(5628):2003;2065-2071.
8. Cayabyab M., Karlsson G.B., Etemad-Moghadam B.A., Hofmann W., Steenbeke T., Halloran M., Fanton J.W., Axthelm M.K., Letvin N.L., Sodroski J.G. Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2). J. Virol. 73(2):1999;976-984.
9. Chan D.C., Fass D., Berger J.M., Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 89(2):1997;263-273.
10. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P.D., Wu L., Mackay C.R., LaRosa G., Newman W., Gerard N., Gerard C., Sodroski J. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85(7):1996;1135-1148.
11. Clavel F., Guetard D., Brun-Vezinet F., Chamaret S., Rey M.A., Santos-Ferreira M.O., Laurent A.G., Dauguet C., Katlama C., Rouzioux C.et al. Isolation of a new human retrovirus from West African patients with AIDS. Science. 233(4761):1986;343-346.
12. Daar E.S., Li X.L., Moudgil T., Ho D.D. High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. Proc. Natl. Acad. Sci. U.S.A. 87(17):1990;6574-6578.
13. Deen K.C., McDougal J.S., Inacker R., Folena-Wasserman G., Arthos J., Rosenberg J., Maddon P.J., Axel R., Sweet R.W. A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature. 331(6151):1988;82-84.
14. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381(6584):1996;661-666.
15. Doranz B.J., Rucker J., Yi Y., Smyth R.J., Samson M., Peiper S.C., Parmentier M., Collman R.G., Doms R.W. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 85(7):1996;1149-1158.
16. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., Cayanan C., Maddon P.J., Koup R.A., Moore J.P., Paxton W.A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381(6584):1996;667-673.
17. Edwards T.G., Hoffman T.L., Baribaud F., Wyss S., LaBranche C.C., Romano J., Adkinson J., Sharron M., Hoxie J.A., Doms R.W. Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein. J. Virol. 75:2001;5230-5239.
18. Everall I.P., Luthert P.J., Lantos P.L. Neuronal loss in the frontal cortex in HIV infection. Lancet. 337(8750):1991;1119-1121.
19. Fauci A.S., Macher A.M., Longo D.L., Lane H.C., Rook A.H., Masur H., Gelmann E.P. NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann. Intern. Med. 100(1):1984;92-106.
20. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272(5263):1996;872-877.
21. Fisher R.A., Bertonis J.M., Meier W., Johnson V.A., Costopoulos D.S., Liu T., Tizard R., Walker B.D., Hirsch M.S., Schooley R.T.et al. HIV infection is blocked in vitro by recombinant soluble CD4. Nature. 331(6151):1988;76-78.
22. Fox L., Alford M., Achim C., Mallory M., Masliah E. Neurodegeneration of somatostatin-immunoreactive neurons in HIV encephalitis. J. Neuropathol. Exp. Neurol. 56(4):1997;360-368.
23. Gabuzda D., Wang J. Chemokine receptors and virus entry in the central nervous system. J. NeuroVirol. 5(6):1999;643-658.
24. Gallo R.C., Salahuddin S.Z., Popovic M., Shearer G.M., Kaplan M., Haynes B.F., Palker T.J., Redfield R., Oleske J., Safai B.et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 224(4648):1984;500-503.
25. Ghorpade A., Nukuna A., Che M., Haggerty S., Persidsky Y., Carter E., Carhart L., Shafer L., Gendelman H.E. Human immunodeficiency virus neurotropism: an analysis of viral replication and cytopathicity for divergent strains in monocytes and microglia. J. Virol. 72(4):1998;3340-3350.
26. Ghorpade A., Xia M.Q., Hyman B.T., Persidsky Y., Nukuna A., Bock P., Che M., Limoges J., Gendelman H.E., Mackay C.R. Role of the beta-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia. J. Virol. 72(4):1998;3351-3361.
27. Gorry P.R., Bristol G., Zack J.A., Ritola K., Swanstrom R., Birch C.J., Bell J.E., Bannert N., Crawford K., Wang H., Schols D., De Clercq E., Kunstman K., Wolinsky S.M., Gabuzda D. Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J. Virol. 75(21):2001;10073-10089.
28. Hayami M., Igarashi T. SIV/HIV-1 chimeric viruses having HIV-1 env gene: a new animal model and a candidate for attenuated live vaccine. Leukemia. 11(Suppl. 3):1997;95-97.
29. He J., Chen Y., Farzan M., Choe H., Ohagen A., Gartner S., Busciglio J., Yang X., Hofmann W., Newman W., Mackay C.R., Sodroski J., Gabuzda D. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature. 385(6617):1997;645-649.
30. Helseth E., Kowalski M., Gabuzda D., Olshevsky U., Haseltine W., Sodroski J. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. J. Virol. 64(5):1990;2416-2420.
31. Igarashi T., Brown C.R., Endo Y., Buckler-White A., Plishka R., Bischofberger N., Hirsch V., Martin M.A. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): implications for HIV-1 infections of humans. Proc. Natl. Acad. Sci. U.S.A. 98(2):2001;658-663.
32. Institute of Laboratory Animal Resources Committee on the Care and Use of Laboratory Animals Guide for the Care and Use of Laboratory Animals. NIH Pub. No. 86-23. 1985;U.S. Dept. of Health and Human Services, Washington, D.C.
33. Joag S.V., Li Z., Foresman L., Stephens E.B., Zhao L.J., Adany I., Pinson D.M., McClure H.M., Narayan O. Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. J. Virol. 70(5):1996;3189-3197.
34. Joag S.V., Li Z., Foresman L., Pinson D.M., Raghavan R., Zhuge W., Adany I., Wang C., Jia F., Sheffer D., Ranchalis J., Watson A., Narayan O. Characterization of the pathogenic KU-SHIV model of acquired immunodeficiency syndrome in macaques. AIDS Res. Hum. Retroviruses. 13(8):1997;635-645.
35. Johnston J.B., Power C. Feline immunodeficiency virus xenoinfection: the role of chemokine receptors and envelope diversity. J. Virol. 76(8):2002;3626-3636.
36. Kaul M., Garden G.A., Lipton S.A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature. 410(6831):2001;988-994.
37. Ketzler S., Weis S., Haug H., Budka H. Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol. (Berl.). 80(1):1990;92-94.
38. Kolchinsky P., Kiprilov E., Sodroski J. Increased neutralization sensitivity of CD4-independent human immunodeficiency virus (HIV-1) variants. J. Virol. 75:2001;2041-2050.
39. Korber B.T.F.B., Kuiken C., Pillai S., Sodroski J.G. Numbering position in HIV relative to HXB2CG. Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. 1998;III-102-III-103 Los Alamos National Laboratories, Los Alamos, NM.
40. Kuiken C.L., Goudsmit J., Weiller G.F., Armstrong J.S., Hartman S., Portegies P., Dekker J., Cornelissen M. Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex. J. Gen. Virol. 76(Pt 1):1995;175-180.
41. Kwong P.D., Wyatt R., Robinson J., Sweet R.W., Sodroski J., Hendrickson W.A. Structure of an HIV pg120 envelope glycoprotein complex with the CD4 receptor and a neutralizing human antibody. Nature. 393:1998;648-659.
42. Letvin N.L. Animal models for AIDS. Immunol. Today. 11(9):1990;322-326.
43. Li J., Lord C.I., Haseltine W., Letvin N.L., Sodroski J. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J. Acquired Immune Defic. Syndr. 5(7):1992;639-646.
44. Li S., Juarez J., Alali M., Dwyer D., Collman R., Cunningham A., Naif H.M. Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates. J. Virol. 73(12):1999;9741-9755.
45. Lipton S.A., Gendelman H.E. Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 332(14):1995;934-940.
46. Luciw P.A., Pratt-Lowe E., Shaw K.E., Levy J.A., Cheng-Mayer C. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc. Natl. Acad. Sci. U.S.A. 92(16):1995;7490-7494.
47. Masliah E., Ge N., Achim C.L., Hansen L.A., Wiley C.A. Selective neuronal vulnerability in HIV encephalitis. J. Neuropathol. Exp. Neurol. 51(6):1992;585-593.
48. Means R.E., Matthews T., Hoxie J.A., Malim M.H., Kodama T., Desrosiers R.C. Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4. J. Virol. 75:2001;3903-3915.
49. Moore J.P., McKeating J.A., Huang Y.X., Ashkenazi A., Ho D.D. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. J. Virol. 66(1):1992;235-243.
50. Murray E.A., Rausch D.M., Lendvay J., Sharer L.R., Eiden L.E. Cognitive and motor impairments associated with SIV infection in rhesus monkeys. Science. 255(5049):1992;1246-1249.
51. Muster T., Steindl F., Purtscher M., Trkola A., Klima A., Himmler G., Ruker F., Katinger H. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67(11):1993;6642-6647.
52. Pierson T., McArthur J., Siliciano R.F. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu. Rev. Immunol. 18:2000;665-708.
53. Posner M.R., Cavacini L.A., Emes C.L., Power J., Byrn R. Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120. J. Acquired Immune Defic. Syndr. 6(1):1993;7-14.
54. Power C., Buist R., Johnston J.B., Del Bigio M.R., Ni W., Dawood M.R., Peeling J. Neurovirulence in feline immunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression. J. Virol. 72(11):1998;9109-9115.
55. Power C., McArthur J.C., Nath A., Wehrly K., Mayne M., Nishio J., Langelier T., Johnson R.T., Chesebro B. Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J. Virol. 72(11):1998;9045-9053.
56. Price R.W. Neurological complications of HIV infection. Lancet. 348(9025):1996;445-452.
57. Puffer B.A., Pohlmann S., Edinger A.L., Carlin D., Sanchez M.D., Reitter J., Watry D.D., Fox H.S., Desrosiers R.C., Doms R.W. CD4-independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity. J. Virol. 76:2002;2595-2605.
58. Reimann K.A., Li J.T., Veazey R., Halloran M., Park I.W., Karlsson G.B., Sodroski J., Letvin N.L. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol. 70(10):1996;6922-6928.
59. Richman D.D., Wrin T., Little S.J., Petropoulos C.J. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. U.S.A. 100(7):2003;4144-4149.
60. Robey W.G., Safai B., Oroszlan S., Arthur L.O., Gonda M.A., Gallo R.C., Fischinger P.J. Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science. 228(4699):1985;593-595.
61. Sanders R.W., Venturi M., Schiffner L., Kalyanaraman R., Katinger H., Lloyd K.O., Kwong P.D., Moore J.P. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol. 76(14):2002;7293-7305.
62. Scanlan C.N., Pantophlet R., Wormald M.R., Ollmann Saphire E., Stanfield R., Wilson I.A., Katinger H., Dwek R.A., Rudd P.M., Burton D.R. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1→2 mannose residues on the outer face of gp120. J. Virol. 76(14):2002;7306-7321.
63. Schrager L.K., D'Souza M.P. Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy. JAMA. 280(1):1998;67-71.
64. Shieh J.T., Albright A.V., Sharron M., Gartner S., Strizki J., Doms R.W., Gonzalez-Scarano F. Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia. J. Virol. 72(5):1998;4243-4249.
65. Si Z., Cayabyab M., Sodroski J. Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P3.2) derived by passage in monkeys. J. Virol. 75:2001;4208-4218.
66. Si Z., Gorry P., Babcock G., Owens C.M., Cayabyab M., Phan N., Sodroski J. Envelope glycoprotein determinants of increased entry in a pathogenic simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) passaged in monkeys. AIDS Res. Hum. Retroviruses. 2004;. (in press).
67. Siliciano R.F. Latency and reservoirs for HIV-1. AIDS. 13(Suppl. A):1999;S49-S58.
68. Smit T.K., Wang B., Ng T., Osborne R., Brew B., Saksena N.K. Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discriminate between patients with and without AIDS dementia complex (ADC): evidence for neurotrophic HIV variants. Virology. 279(2):2001;509-526.
69. Smith D.H., Byrn R.A., Marsters S.A., Gregory T., Groopman J.E., Capon D.J. Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. Science. 238(4834):1987;1704-1707.
70. Sodroski J., Goh W.C., Rosen C., Campbell K., Haseltine W.A. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature. 322(6078):1986;470-474.
71. Stephens E.B., Joag S.V., Sheffer D., Liu Z.Q., Zhao L., Mukherjee S., Foresman L., Adany I., Li Z., Pinson D., Narayan O. Initial characterization of viral sequences from a SHIV-inoculated pig-tailed macaque that developed AIDS. J. Med. Primatol. 25(3):1996;175-185.
72. Stephens E.B., Mukherjee S., Sahni M., Zhuge W., Raghavan R., Singh D.K., Leung K., Atkinson B., Li Z., Joag S.V., Liu Z.Q., Narayan O. A cell-free stock of simian-human immunodeficiency virus that causes AIDS in pig-tailed macaques has a limited number of amino acid substitutions in both SIVmac and HIV-1 regions of the genome and has offered cytotropism. Virology. 231(2):1997;313-321.
73. Sullivan N., Sun Y., Li J., Hofmann W., Sodroski J. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69(7):1995;4413-4422.
74. Takahashi K., Wesselingh S.L., Griffin D.E., McArthur J.C., Johnson R.T., Glass J.D. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann. Neurol. 39(6):1996;705-711.
75. Tan K., Liu J., Wang J., Shen S., Lu M. Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc. Natl. Acad. Sci. U.S.A. 94(23):1997;12303-12308.
76. Thali M., Olshevsky U., Furman C., Gabuzda D., Posner M., Sodroski J. Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody. J. Virol. 65(11):1991;6188-6193.
77. Traunecker A., Luke W., Karjalainen K. Soluble CD4 molecules neutralize human immunodeficiency virus type 1. Nature. 331(6151):1988;84-86.
78. Trkola A., Purtscher M., Muster T., Ballaun C., Buchacher A., Sullivan N., Srinivasan K., Sodroski J., Moore J.P., Katinger H. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70(2):1996;1100-1108.
79. Van Marle G., Rourke S.B., Zhang K., Silva C., Ethier J., Gill M.J., Power C. HIV dementia patients exhibit reduced viral neutralization and increased envelope sequence diversity in blood and brain. AIDS. 16(14):2002;1905-1914.
80. Wei X., Decker J.M., Wang S., Hui H., Kappes J.C., Wu X., Salazar-Gonzalez J.F., Salazar M.G., Kilby J.M., Saag M.S., Komarova N.L., Nowak M.A., Hahn B.H., Kwong P.D., Shaw G.M. Antibody neutralization and escape by HIV-1. Nature. 422(6929):2003;307-312.
81. Weissenhorn W., Dessen A., Harrison S.C., Skehel J.J., Wiley D.C. Atomic structure of the ectodomain from HIV-1 gp41. Nature. 387(6631):1997;426-430.
82. Wyatt R., Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science. 280(5371):1998;1884-1888.
83. Wyatt R., Kwong P.D., Desjardins E., Sweet R.W., Robinson J., Hendrickson W.A., Sodroski J.G. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature. 393(6686):1998;705-711.
84. Yee J.K., Miyanohara A., LaPorte P., Bouic K., Burns J.C., Friedmann T. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 91(20):1994;9564-9568.
85. Zhang K., Rana F., Silva C., Ethier J., Wehrly K., Chesebro B., Power C. Human immunodeficiency virus type 1 envelope-mediated neuronal death: uncoupling of viral replication and neurotoxicity. J. Virol. 77(12):2003;6899-6912.